Concert Pharma (CNCE)
NASDAQ:CNCE
Holding CNCE?
Track your performance easily

Concert Pharma (CNCE) Cash flow

0 Followers

Concert Pharma Cash Flow

CNCE's free cash flow for Q was $-26.05M. For the fiscal year, CNCE's free cash flow was decreased by $13.84M and operating cash flow was $-25.96M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Operating Cash Flow
$ -109.66M$ -55.15M$ -69.04M$ -48.76M$ -48.03M$ 104.08M
Investing Cash Flow
$ -54.13M$ 52.46M$ 344.00K$ 82.58M$ 37.90M$ -121.31M
Financing Cash Flow
$ 155.32M$ 67.13M$ 92.85M$ 1.45M$ -169.00K$ 5.49M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 440.06M$ 142.79M$ 78.36M$ 54.20M$ 18.93M$ 29.22M
Income Tax Paid Supplemental Data
--$ 0.00$ 459.00K$ 123.00K$ 1.90M
Interest Paid Supplemental Data
----$ 0.00$ 648.00K
Issuance Of Capital Stock
$ 115.38M$ 66.99M$ 92.02M$ 115.00K$ 0.00-
Issuance Of Debt
----$ 0.00$ 29.66M
Repayment Of Debt
----$ 0.00$ -30.75M
Free Cash Flow
$ -109.94M$ -55.41M$ -69.25M$ -49.45M$ -50.90M$ 103.14M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Concert Pharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis